Pharmaceuticals 2014, 7(4), 453-463; doi:10.3390/ph7040453
Article

Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug

1,* email, 2email and 3email
Received: 30 December 2013; in revised form: 20 March 2014 / Accepted: 31 March 2014 / Published: 14 April 2014
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The N-ethoxycarbonylmorpholine moiety was evaluated as a novel prodrug moiety for carboxylic acid containing drugs represented by diclofenac (1). Compound 2, the N-ethoxycarbonylmorpholine ester of diclofenac was synthesized and evaluated as a potential prodrug. The stability of the synthesized prodrug was evaluated in solutions of pH 1 and 7.4, and in plasma. The ester’s half lives were found to be 8 h, 47 h and 21 min in pH 1, pH 7.4 and plasma, respectively. Equimolar doses of diclofenac sodium and its synthesized prodrug were administered orally to a group of rabbits in a crossover study to evaluate their pharmacokinetic parameters. The prodrug 2 shows a similar rate and extent of absorption as the parent drug (1). The ulcerogenicity of the prepared prodrug was evaluated and compared with the parent drug. The prodrug showed less ulcerogenicity as detected by fewer number and smaller size of ulcers. In conclusion, the newly synthesized N-ethoxycarbonylmorpholine ester of diclofenac prodrug showed appropriate stability properties at different pHs, similar pharmacokinetic profile, and much less ulcerogenecity at the GIT compared to the parent drug diclofenac.
Keywords: diclofenac; prodrug; ethoxycarbonylmorpholine; pharmacokinetics; ulcerogenicity; prodrug hydrolysis
PDF Full-text Download PDF Full-Text [166 KB, uploaded 14 April 2014 09:35 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Jilani, J.A.; Idkaidek, N.M.; Alzoubi, K.H. Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug. Pharmaceuticals 2014, 7, 453-463.

AMA Style

Jilani JA, Idkaidek NM, Alzoubi KH. Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug. Pharmaceuticals. 2014; 7(4):453-463.

Chicago/Turabian Style

Jilani, Jamal A.; Idkaidek, Nasir M.; Alzoubi, Karem H. 2014. "Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug." Pharmaceuticals 7, no. 4: 453-463.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert